HeimBiotek Recognized as Top Tech Company in Life and Health at 2024 China Overseas Talent Innovation and Entrepreneurship Competition
HeimBiotek has been selected as the "Top Tech Company" in Life and Health at the "2024 China Overseas Talent Innovation and Entrepreneurship Competition," held in Nanning, China, from the 11th to the 13th.
This competition provides a platform for participants to showcase their technology and innovation, with outstanding projects receiving substantial support. The event was hosted by the China Association for Science and Technology and the People's Government of Guangxi Zhuang Autonomous Region, and co-organized by several organizations, including the China International Science and Technology Exchange Center, Guangxi Association for Science and Technology, Nanning People's Government, Nanning Association for Science and Technology, National Offshore Innovation and Entrepreneurship for Overseas Professionals (Nanning), and Shanghai Oracle Bay Group.
The competition featured five categories: Life and Health, Information Technology, Green and Low-Carbon, Advanced Manufacturing, and Future Industry and Cultural Creativity, with a total of 50 teams participating, 10 in each category.
HeimBiotek was recognized as the "Top Tech Company" for its HB miRDx™ EarlyHCC Kit, which utilizes miRNA as a biomarker for early-stage liver cancer (stages 1-2) diagnosis. The HB miRDx™ EarlyHCC Kit is currently undergoing exploratory clinical trials, having demonstrated significant results in two clinical experiments with a total of 500 samples.
